PSA (total)
from £42
The PSA test is a widely accepted blood test used primarily to screen for prostate cancer. The test measures the amount of prostate-specific antigen (PSA) in your blood. PSA is a protein produced by both cancerous and non-cancerous tissue in the prostate gland.
Collection location:
Sample type: Blood
PSA (total and free)
from £72
Measures the ratio of free PSA (not bound to proteins) to PSA bound to proteins. This improves the accuracy of prostate cancer screening and helps distinguish between cancer and benign prostate conditions such as benign prostatic hyperplasia (BPH). Eligibility: anyone with a prostate, of any age.
Collection location:
Sample type: Blood
Stockholm3
from £474
Advanced screening test for prostate cancer including biomarkers and genetics. More accurate than PSA alone, Stockholm3 measures PSA, protein biomarkers and genetic markers to determine your risk of aggressive prostate cancer. It can be used where the PSA is between 1.5-20ng/ml. If your result is above the risk threshold, the results advise that you have further investigation (MRI). If you are at lowest risk, you don't need to retest for 6 years.
Collection location:
Sample type: Blood
Proclarix
from £228
Advanced screening test for prostate cancer, more accurate than PSA alone, used where the PSA is in the "grey area" of 2-10ng/ml. Analyses biomarkers alongside clinical data to detect prostate cancer even where the PSA is low, or rule out prostate cancer where the PSA is elevated for other reasons.
Collection location:
Sample type: Blood
Prostatype
from £1800
Post-diagnostic test on prostate tumour tissue to determine how aggressive the prostate cancer is, and whether you need treatment or are safe on active surveillance.
Collection location:
Sample type: Fingerprick
EarlyCDT Lung
from £180
A non-invasive, advanced blood test that detects lung cancer on average of 4 years, and up to 9 years early than standard clinical diagnosis by analysing biomarkers in the blood which are present at the very earliest stages of lung cancer development.
Collection location:
Sample type: Fingerprick
Bladder EpiCheck
from £228
A non-invasive urine used for early detection of bladder cancer by analysing DNA methylation markers in the urine which indicate presence of a bladder tumour or Upper Tract Urothelial Carcinoma. Detecting these tumours at the earliest stages can allow for non-invasive treatments and good prognosis.
Collection location:
Sample type: Urine
FIT test
from £36
A FIT (Fecal Immunochemical Test) checks for hidden blood in your stool, which can be a sign of colon cancer or other conditions.
Collection location:
Sample type: Feces
Genetic screening
from £594
Your DNA is examined for the presence of 31 genetic variants that increase your risk of developing cancer. Anyone over the age of 18 can take a test, and it is specifically recommended for those with family history of cancer.
Collection location:
Sample type: Saliva